CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
Homologous Recombination
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 16, 2025

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
Kendell Clement1, Jonathan Y Hsu1, Matthew C Canver2
1Molecular Pathology Unit, Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
CRISPR-Cas technology enables precise eukaryotic genome and epigenome editing for biological research and therapeutics. Computational tools are advancing the analysis of on-target and off-target CRISPR editing and pooled screen data.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: